BBOTVSCDT• 28 Days (Normalized)
BBOT vs CDT (BridgeBio Oncology Therapeutics Inc. vs CDT Equity Inc.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
BBOT Performance $3.31
-33.13%
BridgeBio Oncology Therapeutics Inc.
Normalized Baseline0.00%
CDT Performance $0.72
-88.51%
CDT Equity Inc.
Normalized Baseline0.00%
Alpha Spread Margin BBOT LEADS
+55.38 pts
BBOT outperforming by 55.38 percentage points
BBOTCDT
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
BBOT CDT
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | BBOT Price | BBOT Gain (%) | CDT Price | CDT Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $3.31 | -33.13% | $0.72 | -88.51% | +55.38% |
| Oct 08, 2026 | $3.42 | -30.91% | $0.80 | -87.20% | +56.29% |
| Oct 07, 2026 | $3.44 | -30.51% | $0.84 | -86.62% | +56.11% |
| Oct 06, 2026 | $3.50 | -29.29% | $0.93 | -85.12% | +55.83% |
| Oct 05, 2026 | $3.60 | -27.27% | $0.92 | -85.32% | +58.05% |
| Oct 02, 2026 | $3.89 | -21.41% | $0.99 | -84.16% | +62.75% |
| Oct 01, 2026 | $- | $1.25 | -80.00% | - | |
| Sep 30, 2026 | $4.10 | -17.17% | $1.36 | -78.24% | +61.07% |
| Sep 29, 2026 | $3.92 | -20.81% | $1.45 | -76.80% | +55.99% |
| Sep 28, 2026 | $3.81 | -23.03% | $1.90 | -69.60% | +46.57% |
| Sep 25, 2026 | $3.95 | -20.20% | $2.00 | -68.00% | +47.80% |
| Sep 24, 2026 | $3.99 | -19.39% | $3.03 | -51.60% | +32.21% |
| Sep 23, 2026 | $4.16 | -15.96% | $3.38 | -46.00% | +30.04% |
| Sep 22, 2026 | $4.66 | -5.86% | $3.55 | -43.20% | +37.34% |
| Sep 21, 2026 | $4.66 | -5.86% | $3.85 | -38.40% | +32.54% |
Page 1 of 2